IRIFAZE

Medicines for treatment of mucopolysaccharidoses; Medicines for treating metabolism disorder; Bacteriological preparations for medical use; Medicines for treatment of hunter syndrome; Medicines for treating enzyme deficiency; Medicines for treatment of sensory organ diseases; Medicines for treatment of peripheral nervous system disorders; Immunomodulator; Preparations of trace elements for human and animal use, namely, enzymes for medical purposes, enzymes for veterinary purposes, and dietary and nutritional supplements; Medicines for treatment of digestive organ diseases; Medicines for treatment of circulatory organ disorders; Allergy medicines; Cultures of microorganisms for medical use in the nature of cultures for cultivating enzymes; Biological preparations for medical use, namely, biological preparations for treatment of enzyme disorders and enzyme deficiencies; Medicines for treatment of central nervous system disorders; Medicines for treatment of respiratory organ diseases